{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:30:02Z","timestamp":1778697002865,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001531","name":"Asthma and Respiratory Foundation of New Zealand","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001531","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001509","name":"Royal Society of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001509","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12890-017-0511-6","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T15:39:35Z","timestamp":1512401975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effects of treatment changes on asthma phenotype prevalence and airway neutrophil function"],"prefix":"10.1186","volume":"17","author":[{"given":"Collin R.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine J.","family":"Van Dalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Harding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian F.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Douwes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"key":"511_CR1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nri2254","volume":"8","author":"PJ Barnes","year":"2008","unstructured":"Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8:183\u201392.","journal-title":"Nat Rev Immunol"},{"key":"511_CR2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/thorax.57.7.643","volume":"57","author":"J Douwes","year":"2002","unstructured":"Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax. 2002;57:643\u20138.","journal-title":"Thorax"},{"key":"511_CR3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","volume":"160","author":"SE Wenzel","year":"1999","unstructured":"Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999;160:1001\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"511_CR4","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/thx.2006.073429","volume":"62","author":"M Berry","year":"2007","unstructured":"Berry M, Morgan A, Shaw DE, et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax. 2007;62:1043\u20139.","journal-title":"Thorax"},{"key":"511_CR5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","volume":"11","author":"JL Simpson","year":"2006","unstructured":"Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11:54\u201361.","journal-title":"Respirology"},{"key":"511_CR6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.119.5.1329","volume":"119","author":"PG Gibson","year":"2001","unstructured":"Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest. 2001;119:1329\u201336.","journal-title":"Chest"},{"key":"511_CR7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/thx.2006.061358","volume":"62","author":"JL Simpson","year":"2007","unstructured":"Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax. 2007;62:211\u20138.","journal-title":"Thorax"},{"key":"511_CR8","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1164\/ajrccm.160.5.9806170","volume":"160","author":"A Jatakanon","year":"1999","unstructured":"Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med. 1999;160:1532\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"511_CR9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000245899","volume":"79","author":"JL Simpson","year":"2010","unstructured":"Simpson JL, McElduff P, Gibson PG. Assessment and reproducibility of non-eosinophilic asthma using induced sputum. Respiration. 2010;79:147\u201351.","journal-title":"Respiration"},{"key":"511_CR10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/thx.2009.126722","volume":"65","author":"DC Cowan","year":"2010","unstructured":"Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax. 2010;65:384\u201390.","journal-title":"Thorax"},{"key":"511_CR11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1440-1843.2011.02113.x","volume":"17","author":"RJ Hancox","year":"2012","unstructured":"Hancox RJ, Cowan DC, Aldridge RE, et al. Asthma phenotypes: consistency of classification using induced sputum. Respirology. 2012;17:461\u20136.","journal-title":"Respirology"},{"key":"511_CR12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/thoraxjnl-2011-201064","volume":"67","author":"L Fleming","year":"2012","unstructured":"Fleming L, Tsartsali L, Wilson N, Regamey N, Bush A. Sputum inflammatory phenotypes are not stable in children with asthma. Thorax. 2012;67:675\u201381.","journal-title":"Thorax"},{"key":"511_CR13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1183\/09031936.00170110","volume":"38","author":"F Wang","year":"2011","unstructured":"Wang F, He XY, Baines KJ, et al. Different inflammatory phenotypes in adults and children with acute asthma. Eur Respir J. 2011;38:567\u201374.","journal-title":"Eur Respir J"},{"key":"511_CR14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/cyto.b.21069","volume":"84","author":"CR Brooks","year":"2013","unstructured":"Brooks CR, van Dalen CJ, Hermans IF, Douwes J. Identifying leukocyte populations in fresh and cryopreserved sputum using flow cytometry. Cytometry B Clin Cytom. 2013;84:104\u201313.","journal-title":"Cytometry B Clin Cytom"},{"key":"511_CR15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.11-2348","volume":"141","author":"LE Donnelly","year":"2012","unstructured":"Donnelly LE, Barnes PJ. Defective phagocytosis in airways disease. Chest. 2012;141:1055\u201362.","journal-title":"Chest"},{"key":"511_CR16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1034\/j.1399-3003.1999.14d37.x","volume":"14","author":"J Pekkanen","year":"1999","unstructured":"Pekkanen J, Pearce N. Defining asthma in epidemiological studies. Eur Respir J. 1999;14:951\u20137.","journal-title":"Eur Respir J"},{"key":"511_CR17","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1378\/chest.114.5.1343","volume":"114","author":"J Bai","year":"1998","unstructured":"Bai J, Peat JK, Berry G, Marks GB, Woolcock AJ. Questionnaire items that predict asthma and other respiratory conditions in adults. Chest. 1998;114:1343\u20138.","journal-title":"Chest"},{"key":"511_CR18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ije\/25.3.609","volume":"25","author":"MA Jenkins","year":"1996","unstructured":"Jenkins MA, Clarke JR, Carlin JB, et al. Validation of questionnaire and bronchial hyperresponsiveness against respiratory physician assessment in the diagnosis of asthma. Int J Epidemiol. 1996;25:609\u201316.","journal-title":"Int J Epidemiol"},{"key":"511_CR19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rmed.2005.08.012","volume":"100","author":"EF Juniper","year":"2006","unstructured":"Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying 'well-controlled' and 'not well-controlled' asthma using the asthma control questionnaire. Respir Med. 2006;100:616\u201321.","journal-title":"Respir Med"},{"key":"511_CR20","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention report, 2011 update. http:\/\/ginasthma.org ."},{"key":"511_CR21","unstructured":"NAEPP. National Asthma Education and Prevention Program Expert Panel: Guidelines for the Diagnosis and Management of Asthma. 2007; http:\/\/www.nhlbi.nih.gov\/guidelines\/asthma\/asthsumm.pdf ."},{"key":"511_CR22","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1164\/ajrccm.152.3.7663792","volume":"152","author":"ATS","year":"1995","unstructured":"ATS. Standardization of Spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152:1107\u201336.","journal-title":"Am J Respir Crit Care Med"},{"key":"511_CR23","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","volume":"171","author":"ATS\/ERS","year":"2005","unstructured":"ATS\/ERS. ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171:912\u201330.","journal-title":"Am J Respir Crit Care Med"},{"key":"511_CR24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1440-1843.1999.00196.x","volume":"4","author":"KS Jung","year":"1999","unstructured":"Jung KS, Park HS. Evidence for neutrophil activation in occupational asthma. Respirology. 1999;4:303\u20136.","journal-title":"Respirology"},{"key":"511_CR25","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1183\/09031936.06.00034705","volume":"27","author":"E Adelroth","year":"2006","unstructured":"Adelroth E, Hedlund U, Blomberg A, et al. Airway inflammation in iron ore miners exposed to dust and diesel exhaust. Eur Respir J. 2006;27:714\u20139.","journal-title":"Eur Respir J"},{"key":"511_CR26","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.rmed.2006.11.010","volume":"101","author":"J Bosson","year":"2007","unstructured":"Bosson J, Pourazar J, Forsberg B, Adelroth E, Sandstrom T, Blomberg A. Ozone enhances the airway inflammation initiated by diesel exhaust. Respir Med. 2007;101:1140\u20136.","journal-title":"Respir Med"},{"key":"511_CR27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/resp.12079","volume":"18","author":"CR Brooks","year":"2013","unstructured":"Brooks CR, Gibson PG, Douwes J, Van Dalen CJ, Simpson JL. Relationship between airway neutrophilia and aging in asthmatics and non-asthmatics. Respirology. 2013;18:857\u201365.","journal-title":"Respirology"},{"key":"511_CR28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/ajrccm.161.1.9802048","volume":"161","author":"R Louis","year":"2000","unstructured":"Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med. 2000;161:9\u201316.","journal-title":"Am J Respir Crit Care Med"},{"key":"511_CR29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1067\/mai.2001.119411","volume":"108","author":"PG Woodruff","year":"2001","unstructured":"Woodruff PG, Khashayar R, Lazarus SC, et al. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol. 2001;108:753\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"511_CR30","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","volume":"18","author":"SE Wenzel","year":"2012","unstructured":"Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nature Med. 2012;18:716\u201325.","journal-title":"Nature Med"},{"key":"511_CR31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1440-1843.2012.02139.x","volume":"17","author":"P Wark","year":"2012","unstructured":"Wark P. Airway inflammation in asthma, a single measurement is not enough. Respirology. 2012;17:393\u20134.","journal-title":"Respirology"},{"key":"511_CR32","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(99)01813-9","volume":"353","author":"ID Pavord","year":"1999","unstructured":"Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma. Lancet. 1999;353:2213\u20134.","journal-title":"Lancet"},{"key":"511_CR33","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/thorax.57.10.875","volume":"57","author":"RH Green","year":"2002","unstructured":"Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax. 2002;57:875\u20139.","journal-title":"Thorax"},{"key":"511_CR34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1034\/j.1398-9995.1999.00087.x","volume":"54","author":"A Ek","year":"1999","unstructured":"Ek A, Larsson K, Siljerud S, Palmberg L. Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages. Allergy. 1999;54:691\u20139.","journal-title":"Allergy"},{"key":"511_CR35","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.4049\/jimmunol.154.9.4719","volume":"154","author":"G Cox","year":"1995","unstructured":"Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol. 1995;154:4719\u201325.","journal-title":"J Immunol"},{"key":"511_CR36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/ajrccm.161.1.9809100","volume":"161","author":"A Jatakanon","year":"2000","unstructured":"Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med. 2000;161:64\u201372.","journal-title":"Am J Respir Crit Care Med"},{"key":"511_CR37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1164\/ajrccm.160.1.9809104","volume":"160","author":"JC In't Veen","year":"1999","unstructured":"In't Veen JC, Smits HH, Hiemstra PS, Zwinderman AE, Sterk PJ, Bel EH. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med. 1999;160:93\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"511_CR38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1378\/chest.06-2982","volume":"132","author":"K Maneechotesuwan","year":"2007","unstructured":"Maneechotesuwan K, Essilfie-Quaye S, Kharitonov SA, Adcock IM, Barnes PJ. Loss of control of asthma following inhaled corticosteroid withdrawal is associated with increased sputum interleukin-8 and neutrophils. Chest. 2007;132:98\u2013105.","journal-title":"Chest"},{"key":"511_CR39","doi-asserted-by":"crossref","first-page":"L369","DOI":"10.1152\/ajplung.2001.280.2.L369","volume":"280","author":"NE Alexis","year":"2001","unstructured":"Alexis NE, Soukup J, Nierkens S, Becker S. Association between airway hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma. Am J Physiol Lung Cell Mol Physiol. 2001;280:L369\u201375.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"511_CR40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2222.2012.04075.x","volume":"43","author":"JL Simpson","year":"2013","unstructured":"Simpson JL, Gibson PG, Yang IA, et al. Impaired macrophage phagocytosis in non-eosinophilic asthma. Clin Exp Allergy. 2013;43:29\u201335.","journal-title":"Clin Exp Allergy"},{"key":"511_CR41","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1586\/ers.11.76","volume":"5","author":"YJ Huang","year":"2011","unstructured":"Huang YJ, Lynch SV. The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med. 2011;5:809\u201321.","journal-title":"Expert Rev Respir Med"},{"key":"511_CR42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/clim.2000.4911","volume":"97","author":"N Alexis","year":"2000","unstructured":"Alexis N, Soukup J, Ghio A, Becker S. Sputum phagocytes from healthy individuals are functional and activated: a flow cytometric comparison with cells in bronchoalveolar lavage and peripheral blood. Clin Immunol. 2000;97:21\u201332.","journal-title":"Clin Immunol"},{"key":"511_CR43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/cei.12676","volume":"182","author":"T Tak","year":"2015","unstructured":"Tak T, Hilvering B, Tesselaar K, Koenderman L. Similar activation state of neutrophils in sputum of asthma patients irrespective of sputum eosinophilia. Clin Exp Immunol. 2015;182:204\u201312.","journal-title":"Clin Exp Immunol"},{"key":"511_CR44","first-page":"30879","volume":"6736","author":"ID Pavord","year":"2017","unstructured":"Pavord ID, Beasley R, Agusti A, et al. After asthma: redefining airways diseases. Lancet. 2017;6736:30879\u20136. (epublished ahead of print)","journal-title":"Lancet"},{"key":"511_CR45","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1164\/ajrccm.161.5.9906052","volume":"161","author":"RE Aldridge","year":"2000","unstructured":"Aldridge RE, Hancox RJ, Taylor DR, et al. Effects of terbutline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma. Am J Resp Crit Care Med. 2000;161:1459\u201364.","journal-title":"Am J Resp Crit Care Med"},{"key":"511_CR46","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1365-2222.1999.00519.x","volume":"29","author":"S Cianchetti","year":"1999","unstructured":"Cianchetti S, Bacci E, Ruocco L, et al. Salbutamol pretreatment does not change eosinophil percentage and eosinophil cationic protein concentration in hypertonic saline-induced sputum in asthmatic subjects. Clin Exp Allergy. 1999;29:712\u20138.","journal-title":"Clin Exp Allergy"},{"key":"511_CR47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/thx.52.2.136","volume":"52","author":"DW Evans","year":"1997","unstructured":"Evans DW, Salome CM, King GG, et al. Effect of regular inhaled salbutamol on airway responsiveness and airway inflammation in rhinitic non-asthmatic subjects. Thorax. 1997;52:136\u201342.","journal-title":"Thorax"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-017-0511-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T16:53:08Z","timestamp":1693327988000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-017-0511-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1186\/s12890-017-0511-6","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"169"}}